Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 68. Autoimmune Disorders of Connective Tissue
Topics: Introduction | Systemic Lupus Erythematosus | Scleroderma | Sjögren's Syndrome | Polymyositis and Dermatomyositis | Mixed Connective Tissue Disease | Relapsing Polychondritis | Eosinophilic Fasciitis
 
green line

Introduction

In an autoimmune disorder, antibodies or cells produced by the body attack the body's own tissues (see Section 16, Chapter 186). Many autoimmune disorders affect connective tissue in a variety of organs. Connective tissue is the structural tissue that gives strength to joints, tendons, ligaments, and blood vessels (see Section 5, Chapter 58).

In autoimmune disorders, inflammation and the immune response may result in connective tissue damage, not only in and around joints but also in other tissues, including vital organs, such as the kidneys and brain. The sac that surrounds the heart (pericardium), the membrane that covers the lungs (pleura), and even the brain can be affected. The type and severity of symptoms depend on which organs are affected.

An autoimmune disorder of connective tissue is diagnosed on the basis of its particular symptom pattern, the findings during a physical examination, and the results of laboratory tests. Sometimes the symptoms of one disease overlap with those of another so much that doctors cannot make a distinction; in this case, the disorder may be called undifferentiated connective tissue disease or overlap disease.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.